Cargando…
Anti-Vascular Endothelial Growth Factor Therapy in Breast Cancer
Neo-angiogenesis is a critical process for tumor growth and invasion and has become a promising target in cancer therapy. This manuscript reviews three currently relevant anti-angiogenic agents targeting the vascular endothelial growth factor system: bevacizumab, ramucirumab and sorafenib. The effic...
Autores principales: | Kristensen, Tina Bøgelund, Knutsson, Malin L. T., Wehland, Markus, Laursen, Britt Elmedal, Grimm, Daniela, Warnke, Elisabeth, Magnusson, Nils E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284752/ https://www.ncbi.nlm.nih.gov/pubmed/25514409 http://dx.doi.org/10.3390/ijms151223024 |
Ejemplares similares
-
Mechanisms of three-dimensional growth of thyroid cells during long-term simulated microgravity
por: Kopp, Sascha, et al.
Publicado: (2015) -
Biomarkers for Anti-Angiogenic Therapy in Cancer
por: Wehland, Markus, et al.
Publicado: (2013) -
Pathways Regulating Spheroid Formation of Human Follicular Thyroid Cancer Cells under Simulated Microgravity Conditions: A Genetic Approach
por: Riwaldt, Stefan, et al.
Publicado: (2016) -
Effects and Side Effects of Using Sorafenib and Sunitinib in the Treatment of Metastatic Renal Cell Carcinoma
por: Randrup Hansen, Caroline, et al.
Publicado: (2017) -
Hierarchical Classification of Cancers of Unknown Primary Using Multi-Omics Data
por: Bavafaye Haghighi, Elham, et al.
Publicado: (2019)